Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Syngene International Limited (NSE: SYNGENE), ISIN INE398R01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYNGENE last traded at ₹439.80 (+1.17%), with a 52-week range of ₹344.45 to ₹678.95 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.59%, FIIs 10.13%, DIIs 29.31%, mutual funds 27.10%.
EquiSense Score (ECS): 39/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.